Jonathan Birchall

Insider Reports History

Entity
Individual
Location
C/O Phasebio Pharmaceuticals, Inc., 1 Great Valley Parkway, Suite 30, Malvern, PA
Signature
/s/ John P. Sharp, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Birchall:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PhaseBio Pharmaceuticals Inc Chief Commercial Officer Common Stock 20K May 20, 2022 Direct

Insider Reports Filed by Jonathan Birchall

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PHASQ PhaseBio Pharmaceuticals Inc May 20, 2022 1 $13.6K 4 May 24, 2022 Chief Commercial Officer
PHASQ PhaseBio Pharmaceuticals Inc Feb 24, 2022 2 $0 4 Feb 28, 2022 Chief Commercial Officer
PHASQ PhaseBio Pharmaceuticals Inc Nov 8, 2021 1 $843K 4 Nov 9, 2021 Chief Commercial Officer
PHASQ PhaseBio Pharmaceuticals Inc Nov 8, 2021 0 $0 3 Nov 9, 2021 Chief Commercial Officer